Milan Golubović

Milan Golubović

Auto-generated profile, based on publicly available information

Milan Golubović


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
MBMila Bojanovic
Mila Bojanovic
MSMarko Stalević
Marko Stalević
VALENTINA S ARSIC ARSENIJEVICVALENTINA S ARSIC ARSENIJEVIC
VALENTINA S ARSIC ARSENIJEVIC
Aleksandra IgnjatovicAleksandra Ignjatovic
Aleksandra Ignjatovic
MRMarina Ranđelović
Marina Ranđelović
Suzana OtaševićSuzana Otašević
Suzana Otašević
Otomycosis (OM) is a superficial fungal infection of the external auditory canal (EAC) with a worldwide prevalence ranging from 9% to 30%. Commonly, otomycoses are caused by Aspergillus (A.) niger complex and Candida spp. Other causative agents are yeasts of the genera Cryptococcus spp., Rhodotorula spp., Geotrichum candidum, dermatophytes (Trichophyton mentagrophytes), and non-dermatophytes molds (Fusarium spp., Penicillium spp., Mucorales fungi). The widest range of different species causing OM are found in the territories of Iran, India, China, Egypt, Mexico, and Brazil. Fungal infection of the EAC varies from mild to severe forms. It can be acute, subacute, or chronic, and is often unilateral, while the bilateral form is more common in immunocompromised patients. From an epidemiological point of view, tropical and subtropical climates are the most significant risk factor for the development of otomycosis. Other predisposing conditions include clothing habits, EAC hygiene practices, long-term antibiotic therapy, diabetes, and immunodeficiency. Since it is often difficult to distinguish otomycosis from an infection of a different origin, laboratory-based evidence, including standard procedures (microscopy and cultivation), is essential for diagnosis. For the treatment of this superficial fungal infection, there are no official therapeutic guidelines and protocols. However, many antifungals for local application, such as polyene, imidazoles, and allylamines, can be applied, as well as systemic antimycotics (triazoles) in severe forms of infection.

13 August 2020 in Medicina
Verified
Journal Article
Open access
PDF file
Natasa Krsto RancicNatasa Krsto Rancic
Natasa Krsto Rancic
MGMilan B. Golubović
Milan B. Golubović
MIMirko V. Ilić
Mirko V. Ilić
Aleksandra IgnjatovicAleksandra Ignjatovic
Aleksandra Ignjatovic
RŽRadomir M. Živadinović
Radomir M. Živadinović
Suzana OtaševićSuzana Otašević
Suzana Otašević
Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students’ knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials and Methods: A questionnaire-based survey was carried out among 1616 first-year female college students at the University of Niš. It examined socio-demographic characteristics, measured the score of knowledge about cervical cancer, assessed awareness regarding HPV and the HPV vaccine and inquired about the source of information about cervical cancer and HPV. Results: The average cervical cancer knowledge score was 16.35 ± 7.92 (min 0, max 30), with medical professional education, parents’ education level, place of residence and relationship status having significant effects on the score. The awareness about HPV and the HPV vaccine was low, with only 14.2% of students having heard about both HPV and its vaccine. The most commonly reported sources of information were the media, while the most competent one was organized health education. Conclusions: Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.

22 July 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Aleksandra IgnjatovicAleksandra Ignjatovic
Aleksandra Ignjatovic
VALENTINA S ARSIC ARSENIJEVICVALENTINA S ARSIC ARSENIJEVIC
VALENTINA S ARSIC ARSENIJEVIC
MGMilan Golubović
Milan Golubović
SĐSaša Đenić
Saša Đenić
Stefan Desimir MomčilovićStefan Desimir Momčilović
Stefan Desimir Momčilović
Suzana OtaševićSuzana Otašević
Suzana Otašević
Recurrent vulvovaginal candidosis (RVVC) represents a major health problem that significantly affects a patient’s quality of life (QoL). This infection presents with a plethora of clinical manifestation, and this is the first study that carries out a cluster analysis of these signs and symptoms (SS). The goals are to evaluate the distribution of species causing RVVC, their in-vitro susceptibility to antifungals, and the patient’s QoL. Additionally, the clinical characteristics are analyzed using cluster analysis. Prospective analysis of data was performed for women diagnosed with RVVC in the period from January 2016 to December 2019 based on the analysis of data from a single-center’s records. The standard mycological methods and antifungal susceptibility testing were done. Clinical characteristics and QoL were examined by appropriate questions. The cluster analysis was used to identify clusters of SS. A total of 320 women were diagnosed. The dominant species was Candida (C.) albicans. Non-albicans Candida (NAC) yeast was found in 24.4%, and the most common was C. glabrata. Interestingly, Saccharomyces (S.) cerevisiae was detected in 2%. All of the isolated species, except C. parapsilosis and C. kefyr, demonstrated reduced susceptibility to antifungals. We confirmed the emergence of the NAC species and S. cerevisiae with reduced susceptibility to antifungals. Cluster analysis represented by a dendrogram revealed three SS clusters: irritation, uncommon, and discharge, but further studies are needed to examine the relationship between clusters, Candida strains, and outcomes.

15 June 2020 in Acta Medica Medianae
Verified
Journal Article
Open access
MSMarija Stojiljković
Marija Stojiljković
IRIvan Rančić
Ivan Rančić
MGMilan Golubović
Milan Golubović
MJMilica Jakovljević
Milica Jakovljević
MMMirjana Miljković
Mirjana Miljković